Interferons in autoimmune and inflammatory diseases: Regulation and roles

Journal of Interferon and Cytokine Research

Volumn 31, Issue 12, 2011, Pages 857-865

  Choubey, Divaker ^a   Moudgil, Kamal D ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYTOKINE; ESTROGEN RECEPTOR ALPHA; INFLAMMASOME; INTERFERON; NUCLEIC ACID;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; GENDER BIAS; GENOTYPE; HUMAN; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS;

AUTOIMMUNE DISEASES; FEMALE; HUMANS; INFLAMMATION; INTERFERON-ALPHA; INTERFERON-BETA; MALE; MODELS, IMMUNOLOGICAL; SEX FACTORS; SIGNAL TRANSDUCTION;

EID: 83455213857     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0101     Document Type: Review

References (98)

1. Apostolidis SA, Lieberman LA, Kis-Toth K, Crisṕin JC, Tsokos GC. 2011. The dysregulation of cytokine networks in systemic lupus erythematosus. J Interferon Cytokine Res 31(10):769-779.
2. Aringer M, Smolen JS. 2004. Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention. Lupus 13(5):344-347. (Pubitemid 38788494)
3. Astry B, Harberts E, Moudgil KD. 2011. A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis. J Interferon Cytokine Res 31(12):927-940.
4. Baccala R, Gonzalez-Quintial R, Lawson BR, Stern ME, Kono DH, Beutler B, Theofilopoulos AN. 2009. Sensors of the innate immune system: their mode of action. Nat Rev Rheumatol 5(8):448-456.
5. Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN. 2007. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 13(5):543-551. (Pubitemid 46828489)
6. Baechler EC, Gregersen PK, Behrens TW. 2004. The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol 16(6):801-807. (Pubitemid 39423672)
7. Ballestar E, Esteller M, Richardson BC. 2006. The epigenetic face of systemic lupus erythematosus. J Immunol 176(12): 7143-7147. (Pubitemid 43849013)
8. Banchereau J, Pascual V. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25(3):383-392. (Pubitemid 44354221)
9. Barber GN. 2011. Cytoplasmic DNA innate immune pathways. Immunol Rev 243(1):99-108.
10. Barnes B, Lubyova B, Pitha PM. 2002. On the role of IRF in host defense. J Interferon Cytokine Res 22(1):59-71. (Pubitemid 34161283)
11. Bazzoni F, Tamassia N, Rossato M, Cassatella MA. 2010. Understanding the molecular mechanisms of the multifaceted IL-10-mediated anti-inflammatory response: lessons from neutrophils. Eur J Immunol 40(9):2360-2368.
12. Belhocine K, Monack DM. 2011. Francisella infection triggers activation of the AIM2 inflammasome in murine dendritic cells. Cell Microbiol Epub ahead of print; DOI: 10.1111/j.1462-5822.2011.01700.x.
13. Billiau A. 2006. Anti-inflammatory properties of type I interfer-ons. Antiviral Res 71(2-3):108-116.
14. Bolland S, Garcia-Sastre A. 2009. Vicious circle: systemic auto-reactivity in Ro52/TRIM21-deficient mice. J Exp Med 206(8): 1647-1651.
15. 1 mice. Genes Immun 9(3):137-152. (Pubitemid 351351656)
16. Choubey D. 2000. p202: an interferon-inducible negative regulator of cell growth. J Biol Regul Homeost Agents 14(3): 187-192.
17. Choubey D, Duan X, Dickerson E, Ponomareva L, Panchanathan R, Shen H, Srivastava R. 2010. Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity. J Interferon Cytokine Res 30(6):371-380.
18. Choubey D, Kotzin BL. 2002. Interferon-inducible p202 in the susceptibility to systemic lupus. Front Biosci 7:e252-e262.
19. Choubey D, Panchanathan R. 2008. Interferon-inducible Ifi200-faily genes in systemic lupus erythematosus. Immunol Lett 119(1-2):32-41.
20. Choubey D, Panchanathan R, Duan X, Liu H, Liu H. 2011. Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus. J Interferon Cytokine Res 31(12):893-906.
21. Cohen-Solal JF, Jeganathan V, Hill L, Kawabata D, Rodriguez-Pinto D, Grimaldi C, Diamond B. 2008. Hormonal regulation of B-cell function and systemic lupus erythematosus. Lupus 17(6):528-532. (Pubitemid 351955427)
22. Crispín JC, Liossis SN, Kis-Toth K, Lieberman LA, Kyttaris VC, Juang YT, Tsokos GC. 2010. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med 16(2): 47-57.
23. Crow MK, Wohlgemuth J. 2003. Microarray analysis of gene expression in lupus. Arthritis Res Ther 5(6):279-287. (Pubitemid 37407977)
24. Cunningham M, Gilkeson G. 2011. Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol 40(1): 66-73.
25. Davis LS, Hutcheson J, Mohan C. 2011. The role of cytokines in the pathogenesis and treatment of systemic lupus er-ythematosus. J Interferon Cytokine Res 31(10):781-789.
26. Elkon KB, Stone VV. 2011. Type I interferon and systemic lupus erythematosus. J Interferon Cytokine Res 31(11):803-812.
27. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. 2009. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458(7237):509-513.
28. Fish EN. 2008. The X-files in immunity: sex-based differences predispose immune responses. Nat Immunol Rev 8(9):737-744.
29. Gabay C, Lamacchia C, Palmer G. 2010. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 6(4): 232-241.
30. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V. 2011. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3(73):73ra20.
31. Gariglio M, Mondini M, De Andrea M, Landolfo S. 2011. The multifaceted interferon-inducible p200 family proteins: from cell biology to human pathology. J Interferon Cytokine Res 31(1):159-172.
32. Graham RR, Hom G, Ortmann W, Behrens TW. 2009. Review of recent genome-wide association scans in lupus. J Intern Med 265(6):680-688.
33. Greenstein BD. 2001. Lupus: why women? J Women's Health Gender Based Med 10(3):233-239. (Pubitemid 32440408)
34. Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Förster I, Farlik M, Decker T, Du Pasquier RA, Romero P, Tschopp J. 2011. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34(2):213-223.
35. Haas C, Ryffel B, Le Hir M. 1998. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. J Immunol 160(8):3713-3718. (Pubitemid 28176072)
36. Hall JC, Rosen A. 2010. Type I interferons: crucial participants in disease amplification in autoimmunity. Nat Rev Rheumatol 6(1):40-49.
37. Henry T, Brotcke A, Weiss DS, Thompson LJ, Monack DM. 2007. Type I interferon signaling is required for activation of the inflammasome during Francisella infection. J Exp Med 204(5): 987-994. (Pubitemid 46798143)
38. Henry T, Monack DM. 2007. Activation of the inflammasome upon Francisella tularensis infection: interplay of innate immune pathways and virulence factors. Cell Microbiol 9(11): 2543-2551. (Pubitemid 47500508)
39. Honda K, Takaoka A, Taniguchi T. 2006. Type I interferon corrected gene induction by the interferon regulatory factor family of transcription factors. Immunity 25(3):349-360. (Pubitemid 44354220)
40. Hron JD, Peng SL. 2004. Type I IFN protects against murine lupus. J Immunol 173(3):2134-2142. (Pubitemid 38971652)
41. Hu X, Chakravarty SD, Ivashkiv LB. 2008. Regulation of inter-feron and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol Rev 226:41-56.
42. Johnstone RW, Trapani JA. 1999. Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol Cell Biol 19(9):5833-5838. (Pubitemid 29399288)
43. Jones JW, Kayagaki N, Broz P, Henry T, Newton K, O'Rourke K, Chan S, Dong J, Qu Y, Roose-Girma M, Dixit VM, Monack DM. 2010. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci USA 107(21):9771-9776.
44. 1 mice. Genes Immun 8(8):653-662. (Pubitemid 350238435)
45. Kariuki SN, Niewold TB. 2010. Genetic regulation of serum cy-tokines in systemic lupus erythematosus. Transl Res 155(3): 109-117.
46. Kavai M, Szegedi G. 2007. Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus. Autoimmun Rev 6(7):497-502. (Pubitemid 47069975)
47. Kawasaki T, Kawai T, Akira S. 2011. Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoim-munity. Immunol Rev 243(1):61-73.
48. Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, Chandran B. 2011. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated Herpesvirus infection. Cell Host Microbe 9(5):363-375.
49. Kotter I, Gunaydin I, Zierhut M, Stubiger N. 2004. The use of interferon-alpha in Behcet's disease: review of the literature. Semin Arthritis Rheum 33(5):320-335. (Pubitemid 38496041)
50. Kozyrev SV, Alarcon-Riquelme ME. 2007b. The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 40(8):591-601. (Pubitemid 350302184)
51. Kozyrev SV, Lewén S, Reddy PM, Pons-Estel B; Argentine Collaborative Group, Witte T; German Collaborative Group, Junker P, Laustrup H, Gutiérrez C, Suárez A, Francisca González-Escribano M, Mart́in J; Spanish Collaborative Group, Alarcón-Riquelme ME. 2007a. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 56(4):1234-1241. (Pubitemid 46608648)
52. Kuerten S, Lehmann PV. 2011. The immune pathogenesis of experimental autoimmune encephalomyelitis-lessons learned for multiple sclerosis? J Interferon Cytokine Res 31(12):907-916.
53. Lahita RG. 1999. Systemic lupus erythematosus, 3rd ed. San Diego, CA: Academic Press.
54. Lamkanfi M, Dixit VM. 2011. Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol 187(2): 597-602.
55. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, Meller S, Chamilos G, Sebasigari R, Riccieri V, Bassett R, Amuro H, Fukuhara S, Ito T, Liu YJ, Gilliet M. 2011. Neu-trophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3(73):73ra19.
56. Lawson BR, Prud'homme GJ, Chang Y, Gardner HA, Kuan J, Kono DH, Theofilopoulos AN. 2000. Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc. J Clin Invest 106(2):207-215. (Pubitemid 30483124)
57. Li J, Liu Y, Xie C, Zhu J, Kreska D, Morel L, Mohan C. 2005. Deficiency of type I interferon contributes to Sle2-associated component lupus phenotypes. Arthritis Rheum 52(10):3063-3072. (Pubitemid 41447087)
58. Liu Z, Bethunaickan R, Huang W, Ramanujam M, Madaio MP, Davidson A. 2011. IFN-a confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice. J Immunol 187(3):1506-1513.
59. Lu Q, Shen N, Li ZM, Chen SL. 2007. Genomic view of IFN-a response in pre-autoimmune NZB/NZW and MRL/lpr mice. Genes Immun 8(7):590-603. (Pubitemid 350011691)
60. Marshak-Rothstein A. 2006. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6(11):823-835. (Pubitemid 44631651)
61. Martinon F, Tschopp J. 2007. Inflammatory caspases and in-flammasomes: master switches of inflammation. Cell Death Differ 14(1):10-22. (Pubitemid 44911890)
62. McMurray RW, Hoffman RW, Nelson W, Walker SE. 1997. Cytokine mRNA expression in the B/W mouse model of systemic lupus erythematosus-analyses of strain, gender, and age effects. Clin Immunol Immunopathol 84(3):260-268. (Pubitemid 27398025)
63. Morel L. 2010. Genetics of SLE: evidence from mouse models. Nat Rev Rheumatol 6(6):348-357.
64. Moser KL, Kelly JA, Lessard CJ, Harley JB. 2009. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 10(5):373-379.
65. Niewold TB. 2011. Interferon-alpha as a primary pathogenic factor in human lupus. J Interferon Cytokine Res 31(12):887-892.
66. Niewold TB, Kelly JA, Flesch MH, Espinoza LR, Harley JB, Crow MK. 2008. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus er-ythematosus patients. Arthritis Rheum 58(8):2481-2487.
67. Obermoser G, Pascual V. 2010. The interferon-alpha signature of systemic lupus erythematosus. Lupus 19(9):1012-1019.
68. Panchanathan R, Duan X, Shen H, Rathinam VA, Erickson LD, Fitzgerald KA, Choubey D. 2010a. Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus. J Immunol 185(12):7385-7393.
69. Panchanathan R, Shen H, Bupp MG, Gould KA, Choubey D. 2009. Female and male sex hormones differentially regulate expression of Ifi202, an interferon-inducible lupus suscepti bility gene within the Nba2 interval. J Immunol 183(11): 7031-7038.
70. Panchanathan R, Shen H, Zhang X, Ho SM, Choubey D. 2010b. Mutually positive regulatory feedback loop between inter-ferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity. PLoS One 5:e10868.
71. Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, Hornung V, Vogel SN, Szomolanyi-Tsuda E, Fitzgerald KA. 2010. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 11(5):395-402.
72. Rider P, Carmi Y, Guttman O, Braiman A, Cohen I, Voronov E, White MR, Dinarello CA, Apte RN. 2011. IL-1{alpha} and IL-1{beta} recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 187(9):4835-4843.
73. Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, Hodgson S, Hardy LL, Garceau V, Sweet MJ, Ross IL, Hume DA, Stacey KJ. 2009. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323(5917): 1057-1060.
74. Rubtsov AV, Rubtsova K, Kappler JW, Marrack P. 2010. Genetic and hormonal factors in female-biased autoimmunity. Auto-immun Rev 9(7):494-498.
75. Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D. 2010. Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 50(1):1-14.
76. Salloum R, Niewold TB. 2011. Interferon regulatory factors in human lupus pathogenesis. Transl Res 157(6):326-331.
77. Santiago-Raber ML, Baccala R, Haraldsson KM, Choubey D, Stewart TA, Kono DH, Theofilopoulos AN. 2003. Type-I in-terferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 197(6):777-788. (Pubitemid 36350872)
78. Sawalha AH, Harley JB, Scofield RH. 2009. Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes. J Autoimmun 33(1):31-34.
79. Schurgers E, Billiau A, Matthys P. 2011. Collagen-induced arthritis as an animal model for rheumatoid arthritis: focus on interferon-g. J Interferon Cytokine Res 31(12):917-926.
80. Sekigawa I, Okada M, Ogasawara H, Kaneko H, Hishikawa T, Hashimoto H. 2003. DNA methylation in systemic lupus er-ythematosus. Lupus 12(2):79-85. (Pubitemid 36240839)
81. Shaw PJ, McDermott MF, Kanneganti TD. 2011. Inflammasomes and autoimmunity. Trends Mol Med 17(2):57-64.
82. Shen H, Panchanathan R, Rajavelu P, Duan X, Gould KA, Choubey D. 2010. Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity. J Mol Cell Biol 2(5):284-290.
83. Stark GR, Williams BRG, Silverman RH, Schreiber RD. 1999. How cells respond to interferons? Ann Rev Biochem 67: 227-262.
84. Theofilopoulos AN, Kono DH, Beutler B, Baccala R. 2011. In-tracellular nucleic acid sensors and autoimmunity. J Interferon Cytokine Res 31(12):867-886.
85. Theofilopoulos AN, Koundouris S, Kono DH, Lawson BR. 2001. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res 3(3):136-141. (Pubitemid 32303429)
86. Tsokos GC, Kammer GM. 2000. Molecular aberrations in human systemic lupus erythematosus. Mol Med Today 6(11): 418-424.
87. Tweezer-Zaks N, Rabinovich E, Lidar M, Livneh A. 2008. Interferon-alpha as a treatment modality for colchicine-resistant familial Mediterranean fever. J Rheumatol 35(7): 1362-1365. (Pubitemid 352000785)
88. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, Sirois CM, Jin T, Latz E, Xiao TS, Fitzgerald KA, Paludan SR, Bowie AG. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11(11): 997-1004.
89. van Baarsen LG, van der Pouw Kraan TC, Kragt JJ, Baggen JM, Rustenburg F, Hooper T, Meilof JF, Fero MJ, Dijkstra CD, Polman CH, Verweij CL. 2006. A subtype of multiple sclerosis defined by an activated immune defense program. Genes Immun 7(6):522-531. (Pubitemid 44323686)
90. van Baarsen LG, Vosslamber S, Tijssen M, Baggen JM, van der Voort LF, Killestein J, van der Pouw Kraan TC, Polman CH, Verweij CL. 2008. Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients. PLoS One 3(4):e1927.
91. van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA. 2011. Inflammasome activation and IL-1b and IL-18 processing during infection. Trends Immunol 32(3):110-116.
92. van der Pouw Kraan TC, van Baarsen LG, Wijbrandts CA, Voskuyl AE, Rustenburg F, Baggen JM, Dijkmans BA, Tak PP, Verweij CL. 2008. Expression of a pathogen-response program in peripheral blood cells defines a subgroup of rheumatoid arthritis patients. Genes Immun 9(1):16-22. (Pubitemid 351150030)
93. van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Voskuyl AE, Rustenburg F, Baggen JM, Ibrahim SM, Fero M, Dijkmans BA, Tak PP, Verweij CL. 2007. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 66(8):1008-1014. (Pubitemid 47122311)
94. Verthelyi D, Petri M, Ylamus M, Klinman DM. 2001. Dis-association of sex hormone levels and cytokine production in SLE patients. Lupus 10(5):352-358. (Pubitemid 32536658)
95. Vilaysane A, Muruve DA. 2009. The innate immune response to DNA. Semin Immunol 21(4):208-214.
96. Weckerle CE, Niewold TB. 2011. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol 40(1): 42-49.
97. Whitacre CC. 2001. Sex differences in autoimmune disease. Nat Immunol 2(9):777-780.
98. Zhao S, Wang Y, Liang Y, Zhao M, Long H, Ding S, Yin H, Lu Q. 2011. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 63(5): 1376-1386.